# Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination

> **NCT01499914** · PHASE4 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 439 (actual)

## Conditions studied

- Cystic Fibrosis With Gastrointestinal Manifestation

## Interventions

- **BIOLOGICAL:** influenza vaccination

## Key facts

- **NCT ID:** NCT01499914
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-01
- **Final completion:** 2012-12
- **Target enrollment:** 439 (ACTUAL)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01499914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01499914, "Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01499914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*